-
-
-
rp175418-1mgWnt-inhibitory factor
-
rp175418-500μgWnt-inhibitory factor
-
W648980-10mgWnt/β-catenin agonist 1 (compound 3f) is a Wnt/β-catenin signalling pathway agonist, with an EC 50 of 0.27 μM.In VitroEC50: 0.27 μM (Wnt/β-catenin). MCE has not independently confirmed the accuracy of these methods. They are for reference
-
W648980-25mgWnt/β-catenin agonist 1 (compound 3f) is a Wnt/β-catenin signalling pathway agonist, with an EC 50 of 0.27 μM.In VitroEC50: 0.27 μM (Wnt/β-catenin). MCE has not independently confirmed the accuracy of these methods. They are for reference
-
W648980-5mgWnt/β-catenin agonist 1 (compound 3f) is a Wnt/β-catenin signalling pathway agonist, with an EC 50 of 0.27 μM.In VitroEC50: 0.27 μM (Wnt/β-catenin). MCE has not independently confirmed the accuracy of these methods. They are for reference
-
W655655-1mlWnt/β-catenin agonist 1 (compound 3f) is a Wnt/β-catenin signalling pathway agonist, with an EC 50 of 0.27 μM.In VitroEC50: 0.27 μM (Wnt/β-catenin). MCE has not independently confirmed the accuracy of these methods. They are for reference only.
-
W650792-10mgWnt/β-catenin agonist 2 is a potent Wnt agonist. Wnt/β-catenin agonist 2 activates Wnt/β-catenin signaling and can be used in the research of diseases related to the signal transduction. (From patent WO2007078113A1, compound 39)In VitroWnt/β-catenin
-
W650792-25mgWnt/β-catenin agonist 2 is a potent Wnt agonist. Wnt/β-catenin agonist 2 activates Wnt/β-catenin signaling and can be used in the research of diseases related to the signal transduction. (From patent WO2007078113A1, compound 39)In VitroWnt/β-catenin
-
W650792-50mgWnt/β-catenin agonist 2 is a potent Wnt agonist. Wnt/β-catenin agonist 2 activates Wnt/β-catenin signaling and can be used in the research of diseases related to the signal transduction. (From patent WO2007078113A1, compound 39)In VitroWnt/β-catenin
-
W650792-5mgWnt/β-catenin agonist 2 is a potent Wnt agonist. Wnt/β-catenin agonist 2 activates Wnt/β-catenin signaling and can be used in the research of diseases related to the signal transduction. (From patent WO2007078113A1, compound 39)In VitroWnt/β-catenin